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Title: 3D bioprinting for musculoskeletal applications  
 
Abstract 
This review focuses on developments in the field of bioprinting for musculoskeletal tissue 
engineering, along with discussion on the various approaches for bone, cartilage and 
connective tissue fabrication.  All approaches (cell-laden, cell-free and a combination of both) 
aim to obtain a complex, living tissues able to develop and mature, using the same fundamental 
technology. To date, co-printing of cell-laden and cell-free materials has been revealed to be 
the most promising approach for musculoskeletal applications because materials with good 
bioactivity and good mechanical strength can be combined within the same constructs.  
Bioprinting for musculoskeletal applications is a developing field, and detailed discussion on 
the current challenges and future perspectives is also presented in this review.   
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1. Introduction  
Every 30 seconds, a patient dies from a condition that could be treated with organ replacement 
[1]. Organ transplantation has potential to be an efficient solution but is restricted due limited 
donor availability. Furthermore, organ transplantation requires complex surgical interventions 
and can lead to complications, such as organ dysfunction or rejection. Successful translation of 
tissue engineering and regenerative medicine research is key to alleviating the challenges in 
organ transplantation, but can also be applied to disease modelling and drug discovery (Figure 
1). More specifically, improved understanding of the biological architecture and natural repair 
processes in adult tissues could aid the challenging fabrication of de novo organs, for these 
applications. For cells to self-assemble into tissues, they need an environment in which cells 
can remain viable and are able to adhere and migrate.  The most important factors to consider 
are growth factors, nutrients, adhesion molecules, cells, materials and the technologies applied 
to enhance the fabrication process [2]. This review focuses on developments in bioprinting for 
musculoskeletal tissue engineering, and provides discussion on the various approaches for 
bone, cartilage and connective tissue fabrication, along with current challenges and future 
perspectives. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Translating tissue engineering and regenerative medicine research into 
healthcare applications for the future, including organ/ tissue transplantation, disease 
modelling and drug discovery. 
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2. Bioprinting and its role in musculoskeletal tissue fabrication  
The musculoskeletal system (MSK) provides structural support for the body and comprises of 
vital tissue components such as bone, cartilage, muscles, tendons and ligaments. When these 
tissues are damaged through injury, their repair remains challenging due to their limited 
regenerative potential.  
 
Every year, over 2 million bone grafts are performed worldwide, due to diseases, sarcomas, or 
trauma injuries [3]. In the US, musculoskeletal injuries reach 32 million per year, of which, 
45% are represented by tendon, ligament, and joint capsular injuries [4]. Autografts are 
considered as the gold standard procedure for treating small MSK defects due to their 
compatibility with patients. However, obtaining these grafts causes defects in secondary sites 
and can delay patient recovery time. Furthermore, autografts contribute additional trauma 
injury and are limited by size.  
 
For bigger defects, allogenic or biomaterial grafts are used. However, the use of allogenic grafts 
has several disadvantages including: immune rejection, the necessity for multiple surgical 
procedures to remove donor  material, cost and limited tissue regeneration and 
revascularisation potential [5]. Synthetic grafts can also inhibit vascularisation and de novo 
tissue formation [6]. Tissue engineering advances can provide solutions to these problems. 
Nevertheless, traditional tissue engineering approaches are slow and cannot be used for large 
scale production of biological matter with the required complexity.  
 
Bioprinting promises fast, on demand, and automated manufacturing of high resolution 
constructs. The process involves the use of 3D printing technologies to deposit cells or 
biological factors into predefined shapes and sizes [7]. Bioprinting permits stringent control on 
placement of cells within matrices and enables the arrangement of biological materials within 
composite, hierarchical structures and, patterns. This promises new opportunities to fabricate 
reproducible, patient-specific grafts with low risk of immune rejection.  The most popular and 
promising bioprinting techniques include inkjet and extrusion printing. However, laser-assisted 
technologies are also in development [7]. Details on the various 3D bioprinting techniques are 
reported elsewhere [8].  
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To date, several research groups have bioprinted materials and cells for musculoskeletal 
applications. The two most common approaches used for 3D bioprinting, include the printing 
of cell-free and cell-laden materials. Tables 1 and 2 outline how bone, cartilage, muscle, tendon 
and ligament tissues have been fabricated using these approaches. Figure 2, summarises the 
benefits of each approach.  
 
Figure 2. 3D printing approaches for musculoskeletal tissue fabrication. The advantages 
and disadvantages of cell-free or cell-laden 3D printing.  
 
The current literature suggests that synthetic materials are more widespread for cell-free 
printing, while natural polymers have been commonly combined with cells, prior to extrusion. 
To evaluate the most popular approaches and materials used for bioprinting of musculoskeletal 
tissues, we reviewed the literature published in this area during the last 15 years. Figure 3 
summarises the various materials used for 3D printing using cell-free and cell-laden approaches 
in MSK tissue engineering. The data suggests that around 84% of the materials used for cell-
free printing are synthetic. This is primarily because these materials provide the strong 
mechanical properties required for musculoskeletal applications. The remaining 16% of 
articles show feasibility of this cell-free approach using natural materials (such as collagen, 
alginate) and this can be due to their higher biocompatibility compared to synthetic materials. 
One good example of cell-free printing for bone repair focussed on composite scaffold printing, 
where PCL-hydroxyapatite-carbon nanotubes were printed with pores in the range of 450–700 
µm (Figure 4) [9]*. Results show that a 4 MPa compressive strength was obtained and this is 
analogous to trabecular bone. The composite scaffolds also exhibited enhanced cell adhesion 
and improved hydroxyapatite bioactivity, when seeded with MG63 osteoblast-like cells. 
Nevertheless, the materials were distinct from native bone due to the presence of PCL and 
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carbon nanotubes, and the cells were seeded in a traditional engineering approach. This led to 
uneven cell seeding/ distribution.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Percentage of various materials used in A) cell-free and (B) cell-laden printing 
for musculoskeletal applications. The data is based on articles published in the last 15 years 
using the search terms “3D printing”, “bioprinting” and “bioink” associated with “bone”, 
“cartilage”, “osteochondral”, “muscle”, “tendon” and “ligament”.  
 
In the literature, naturally-derived biomaterials such as alginate [10,11], collagen [11], gelatine 
and fibrin [12], have successfully promoted cell adhesion, proliferation and osteochondral 
differentiation with both cell-free and cell-laden printing approaches. However, natural 
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materials were the most common materials used for cell-laden printing (70% of total reported 
in literature, Fig 3B) for musculoskeletal applications. This is predominantly because of their 
capacity to form gels that can support cell encapsulation and survival during the 3D printing 
process.  
 
Figure 4. Structural properties of PCL-hydroxyapatite composites strengthened with 
carbon nanotubes for bone repair. (A) Technical drawing, (B) 3D simulation and (C) printed 
3D scaffold with square pores. Image adapted with permission from [9]. 
 
Due to their poor mechanical properties, some of these natural biomaterials have been co-
printed with other synthetic polymers for musculoskeletal applications. This can be realised by 
using multi-tool printing, which requires special modifications to printers, such as 
incorporation of additional print heads or extruders. Daly et al. used multi-tool printing to 
produce a mechanically reinforced cartilaginous template mimicking the geometry of a 
vertebral disk [13]. In this approach developmental precursors to an adult organ were 
bioprinted and the engineered construct functioned as a template for subsequent organogenesis 
in vivo. This was achieved by printing a PCL template, followed by the deposition of a RGD-
alginate hydrogel laden with adult stem cells, as shown in Figure 5. When implanted into a 
mouse model, the resultant bioprinted construct supported the development of vascularised 
bone containing trabecular-like endochondral bone with a supporting marrow structure. 
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Figure 5. Bioprinting of vertebrae-shaped bioinks with enhanced mechanical 
properties for bone regeneration. (A) Multi-tool 3D printing was applied to produce a 
composite vertebrae structure by depositing PCL filaments followed by an MSC-laden bioink 
(RGD-alginate). (B) MicroCT analysis to illustrate the distribution of the bioink and PCL. (C) 
Live/ dead images of MSCs within the bioprinted vertebrae. Image taken with permission from 
[13]. 
 
In another example using multi-tool printing, the vascularised bone was engineered when PLA 
was deposited with FDM printing technology, while GelMA containing BMP and VEGF was 
co-printed using SLA [14]**. This study demonstrated that the dual 3D printed constructs 
provided a hierarchically biomimetic bone-like structure, with multiphasic characteristics and 
potential for vascularised bone regeneration, as shown in Figure 6. This is a noteworthy 
approach to produce complex tissue structures in the lab. However, it is important to stringently 
assess the functionality of this vascularised bone and make quantitative comparisons with 
native tissues. 
 
 
Figure 6. Production of engineered vascularised bone via 3D printing. Schematic 
illustration of the biomimetic architectural design and hierarchical fabrication process for 
printing of biphasic vascularised bone constructs using a FDM/ SLA platform. Image taken 
with permission from [14]. 
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In addition to this work, interesting results have been obtained using synthetic materials. Poly 
(ethylene glycol) dimethyl acrylate (PEG-GelMA) was successfully inkjet printed with human 
chondrocytes for the repair of small osteochondral defects [15]. In another study, bone and 
cartilage tissues were fabricated through inkjet printing of human mesenchymal stem cells and, 
simultaneous deposition and photo-crosslinking of PEG-GelMA [16]. Others have achieved 
minimal print-head clogging by printing acrylate peptides and PEG hydrogels with human 
mesenchymal stem cells to promote robust bone and cartilage formation [17]. Porous bioactive 
glass/ alginate composite scaffolds have also been fabricated for bone tissue engineering using 
3D printing [18]. 
As a prospective treatment for cartilage lesions, recent study reported use of 3D bioprinting 
approach to form cartilage mimetics using a nano-fibrillated cellulose and alginate-based 
composite bioink seeded with human-derived induced pluripotent stem cells (iPSCs) and 
human chondrocytes [19]. The bioprinted constructs could maintain pluripotency initially, and 
after five weeks, hyaline-like cartilaginous tissue with collagen type II expression, lacking 
tumorigenic OCT4 expression was observed. Furthermore, a significant increase in cell number 
within the cartilaginous tissue was detected. This study combines 3D printing and stem cell 
technology to generate viable tissues for clinical applications.  
While the majority of studies focus on bone and cartilage regeneration, recent work has shown 
progress in the bioprinting of other musculoskeletal tissues, such as muscles and tendons. An 
Integrated Tissue-Organ Printer (ITOP) was used for the fabrication of skeletal muscle 
structures. The approach was based on the printing of well-defined PCL patterns for directional 
alignment of the muscle cells, as shown in Figure 7. At the same time, cells were deposited 
using a mixture of hydrogels (gelatine, hyaluronic acid and fibrinogen), which were loaded 
with mouse myoblasts cells. Results showed good cell viability, and alignment along the PCL 
pillars/ patterns and muscle-like structures were observed after 7 days. When the constructs 
were implanted in vivo, they integrated with the common peroneal nerve (CPN) after 2 weeks 
and the muscle was seen to respond to electrical stimuli [20]. Even though bioprinting 
examples in this area are limited, this study provides good evidence that 3D printing can be 
used for the development of various fibrous tissues (muscle, tendon and ligament) where 
cellular alignment is a key requirement [21].   
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Figure 7. Bioprinting of skeletal muscle and implantation in vivo. (A) and (B) scaffold 
design; (C) scaffold fabrication; cell alignment with PCL (D) and without PCL (E); F) Live/ 
dead assay: green cells are alive and red cells are dead; (G) Immunofluorescent staining for 
myosin heavy chain of the 3D printed muscle after 7D differentiation. The encapsulated 
myoblasts aligned along the longitudinal direction of the fibre structure; (H) schematic of the 
ectopic implanted scaffold in vivo; (I) implanted scaffold next to the common peroneal nerve 
(CPN) and (J) immunostaining for Desmin. Adapted from [20] with permission from Nature 
publishing group. 
 
While various materials have been used as bioinks for printing cell-free and cell-laden 
constructs, cells alone in the form of tissue spheroids have also been investigated for 3D 
bioprinting. Printed cells have a fluid nature and over time, they fuse together to form more 
complex cell aggregates that can potentially lead to tissue formation [22]. In the literature, 
tissue spheroids have already been successfully used for cartilage tissue engineering [23-25]. 
However, successful production of constructs using tissue spheroids is still in its infancy and 
focus needs to be applied on utilising 3D printing technologies to help with scale-up, 
reproducibility and formation of more complex structures [26,27].  
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Breakdown of the materials used as bioinks for bone and cartilage bioprinting in the last 15 
years, show some interesting trends. The majority of all the cell-free approaches used materials 
such as PCL, -TCP or hydroxyapatite (Figure 3). In contrast, alginate was the most popular 
material for cell-laden bioinks (25%) and this was followed by PCL (21%) and collagen (9%). 
Alginate was applied due to its good printability, while PCL is a biocompatible mechanical 
strength enhancer of the cell-laden hydrogels. Notably, there is greater variety in the materials 
used for cell-laden printing than cell-free printing.  
3D printing has been successfully applied in a variety of ways to address the growing demand 
for more robust musculoskeletal therapies. Nevertheless, the use of the technology for medical 
purposes is still in its infancy. There is need for further research and development in both 3D 
printing technology and bio-ink formulations for successful translation of this technology in 
future.   
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Biomaterials Cells 
Printing 
Technique 
Application Construct Morphology 
Mechanical Properties 
 
Advantages (A)/ Disadvantages (D) Reference 
PLGA + PLA 
(cartilage) and PLGA + 
tricalcium phosphate 
(TCP) (bone) with 
gradients at interface 
Ovine Articular 
Chondrocytes 
Inkjet: 
TheriFormTM 
Osteochondral 
3 regions:  4 mm cloverleaf bone 
region with 55% porosity, 1.2 
mm transition region with three 
gradient sections 2 mm 
cartilaginous region with 90% 
porosity and staggered 250 μm 
channels. 
Tensile data: a. tensile strength 1.6-5.7 MPa 
b. elastic modulus 83-233 MPa 
 
Compressive data: a. yield strength 2.5-13.7 
b. elastic modulus 54-450 MPa 
 
Diameter shrinkage: cartilage region 8.3% and 
adjacent transition zones 3.8% 
A: Homogeneous cell seeding (material gradients at the 
interface) and no delamination. 
D: Compressive properties of the bone region of the construct 
are lower than those of cancellous bone. 
[28] 
Hydroxyapatite (HA) 
Mouse Pre-
Osteoblasts 
(MC3T3-E1) 
Indirect 
writing 
(powder + 
binding 
solution) 
Cartilage 
Internal structure: walls that all 
stand in 45º to the x-axis with 
1.2 mm of distance between 
them with 500 μm 
interconnecting channels. 
Shrinkage after sintering: 18-20% in all 
directions 
A: Cells cultured in static and dynamic conditions. Multiple 
cell layers on the surface of the HA granules (static) and cell 
proliferation inside granule cavities (dynamic). 
D: Mechanical properties not evaluated. 
[29] 
PLGA 
Human Foetal 
Osteoblasts 
Inkjet: 
ZPrinter 310 
PLUSTM 
Bone 
6 mm in diameter and 6 mm in 
height with interconnected 
channels. 1 mm pores and 55% 
porous. Rough Macro porous 
surface. 
Compressive strength: 7.8 ± 3.1 MPa 
 
Compressive Young’s modulus: 77.2 ± 10.8 
MPa 
A: Mechanical properties mimic human cancellous bone and 
supports osteoblasts proliferation.                                                        
D: Mechanical properties still lower than the ones of human 
cortical bone. 
[30] 
PCL/ HA (shifted 
pattern) 
Human 
Osteosarcoma 
(MG 63) 
Bioplotter Bone 
5 × 5 × 5 mm3 scaffolds. Square 
lattice with 380-400 μm strands 
to generate porous structure. 600 
μm pores with 92.55% porosity 
and. Shifted patterns. 
Compressive modulus: ~22 MPa 
A: Promotes cell attachment, proliferation and differentiation. 
Increased cell attachment by shifted pattern structure. 
D: Low compressive modulus. 
[31] 
Mesoporous bioactive 
glass (MBG) + Alginate 
Human Bone 
Marrow-derived 
MSCs (hBMSC) 
Bioplotter Bone 
8 × 8 × 8 mm3 square lattice 
scaffolds. 50% to 67% porosity. 
Internal structure: micro- and 
macro-pores with Nano channels 
(5 nm). 
Compressive strength: 0.4-1.6 MPa 
 
Compressive modulus: 1.4-6 MPa 
 
Shrinkage after drying at room temperature:  
~30% 
 
A: Good mechanical properties with improved cell attachment 
compared to pure alginate only. Promotes cell proliferation 
and differentiation.                                                   D: 
Mechanical properties decrease after incubation with 
simulated body fluid. 
[18] 
Collagen + Alginate + 
Silica 
Mouse Pre-
Osteoblasts 
(MC3T3-E1) 
Low 
temperature 
Bioplotter 
Bone 
Multi-layered cylindrical struts 
(324-389 μm) with mesh-like 
interconnected structure. Highly 
porous (>78%) with 468–481 
μm average pore size. 
Tensile Young’s modulus: 1.96 ± 0.19 MPa 
 
Max. tensile strength: 0.12 ± 0.03 MPa 
 
Compressive Young’s modulus: ~0.2-0.3 MPa 
 
A: Biocompatibility, osteo-induction and production of bone-
like HA. Silica improved mechanical properties compared to 
collagen + alginate hydrogels only. 
D: 2-step scaffold fabrication and cell seeding, with >7-day 
coating process that can cause blocked pores. 
[11] 
Silicon-doped Nano 
Crystalline HA + PCL 
+ Carbon Nanotubes 
(CNT) 
Human 
Osteosarcoma 
(MG 63) 
Pneumatic 
EnvisionTEC 
3D 
Bioplotter® 
Bone 
Multi-layered lattice. 7 layers 
with 6 mm diameter and 3 mm 
height.  Interconnected square 
450-700 μm pores. 
Compressive strength: ~4 MPa 
 
Compressive elastic modulus: 50 MPa 
A: CNTs improve cell attachment. 2% CNT scaffolds improve 
mechanical properties and electrical conductivity. 
D: Scaffolds loaded with more than 2% CNTs decrease 
compressive resistance and porosity (40 %). 
[9] 
GelMA 
MG63 
osteoblast-like 
cells 
Primary normal 
human 
Customised 
bioprinter 
Bone 
Pores size 400 μm, thickness 
750 μm 
Hydrogel with 8% GelMA 
Before Crosslinking: storage modulus 100 Pa 
After UV Crosslinking: storage modulus 1000 
Pa 
A: Storage modulus permits printing of the hydrogel before 
crosslinking, and UV-crosslinking ensure suitable mechanical 
properties to stimulate osteoblasts proliferation. GelMA 
hydrogel has successfully been used to coat titanium.  
D: Low cell viability 
[32]  
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Table 1. Cell-free approach for bioprinting of musculoskeletal tissues.  
osteoblasts 
(NHOst) 
PCL + PLGA + Duck 
Beak 
New Zealand 
White rabbit in 
vivo study with 5 
mm critical 
defects 
Bioprinting: 
multi head 
pneumatic 
syringe 
dispenser 
Bone 
3 × 3 × 20 mm oblong scaffolds 
with 77.3% porosity and 2.787 
μm pores.  
 
Compressive strength: 17 MPa 
A: Promotes repair and de novo bone formation. High 
compressive strength compared to PCL/ PLGA implanted 
scaffolds. 
D: Irregular scaffold shape and pore structure/ distribution. 
[33] 
PLA+HA 
In vivo 
implantation of 
MSCs from New 
Zealand Rabbits  
Desktop 3D 
printer (Dot 
Go 3D 
Technology 
Corporation, 
Xiangtan, 
China) 
Anterior Cruciate 
Ligament 
Screw-like scaffold, 10 x 2.1 x 
2.1 mm 
Pores  ~290 μm 
 
N/A 
A: In vivo work showed good bone/ graft interface and 
successful tendon healing within bone tunnel.  
D: No mechanical test and scaffold not representative of 
physiological environment. 
[34] 
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Biomaterials Cells 
Printing 
Technique 
Application Construct Morphology Material Properties Advantages/ disadvantages Reference 
Lutrol F127 + Matrigel® 
+ Alginate + 
Methylcellulose + Agarose 
Goat Bone 
Marrow Stromal 
Cells 
Pneumatic 
EnvisionTEC 3D 
Bioplotter® 
Bone 
20x20 mm rectangular 3D 
scaffolds with 300 μm spacing 
between fibres and 150 μm 
layer thickness. 
N/A 
A: Cell viability not affected by printer nozzle. Materials promoted cell 
proliferation and differentiation into osteogenic lineage.                                                 
D: Hydrogels stiffness leading to fusion of adjacent layers, and no transverse 
pores. 
[35] 
Alginate 
Human Articular 
Chondrocytes + 
Human 
Mesenchymal 
Stem Cells 
(hMSCs) 
BioScaffolderTM 
pneumatic system 
Osteochondral 
Ten-layer rectangular 3D 
scaffolds (10×10 mm) with 
spacing between fibres of 0.8-
2.5 mm. 100 μm layer 
thickness. 
Viscosity: 0.5-1000 Pa. s 
 
A: Controlled cell distribution/ encapsulation in hydrogels. Combine multiple 
cell types. 
D: Poor mechanical strength of alginate and fused transversal pores. 
[10] 
Cell-laden Alginate 
surrounding cell-free 
PCL (cell-free) 
Human 
Chondrocytes 
(C20A4) 
BioScaffolderTM 
pneumatic system 
Hard tissue 
6×60×2 mm rectangular lattice 
scaffolds with 2 μm fibre 
spacing. 
Young’s modulus: ~6.5 
MPa 
A: PCL improves mechanical properties of alginate.                                                                          
D: High deposition temperatures of PCL are detrimental to cell viability in 
alginate. 
[36] 
PCL + PLGA + 
Atelocollagen 
Mouse Pre-
Osteoblasts 
(MC3T3-E1) 
Bioprinting: multi 
head pneumatic 
syringe dispenser 
Heterogeneous 
Tissue 
Hybrid scaffold with alternated 
layers of synthetic and natural 
materials, with 400 µm fibres. 
N/A 
A: Scaffold promotes cell proliferation and good viability. 
D: No consideration of mechanical properties. 
[37] 
PCL + Hyaluronic acid + 
Atelocollagen 
Human 
Mesenchymal 
Stromal in Rabbit 
Knee 
Bioprinting: multi 
head pneumatic 
syringe dispenser 
Osteochondral 
Hydrogels with 250 µm and 
500 µm pores, between 250 
µm PCL fibres. 5 mm rabbit 
knee defect filled. 
N/A 
A: Multilayered constructs without chemical or physical crosslinking. PCL 
allowed cell rich hydrogels with controlled structure. 
D: No consideration of mechanical properties. 
 
[38] 
Poly (ethylene glycol) 
dimethacrylate 
(PEGDMA) 
Human Articular 
Chondrocytes 
Thermal Inkjet 
Printer: Hewlett-
Packard Deskjet 
500 
Cartilage 
Cylindrical osteochondral 
plugs, 4 mm 
in diameter and 2 mm in depth. 
Compressive modulus: 
321.06 ± 43.99 kPa 
 
Swelling ratio: 6.10-
11.80% 
 
 
A: Simultaneous photo-polymerisation during 3D printing to maintain precise 
cell position during layer-by-layer assembly.  Integrated layers decrease 
delamination risk. Compressive modulus comparable to native human articular 
cartilage. Biocompatibility and promotion of chondrocyte growth. 
D: Compressive module lower than non-printed PEGDMA due to thermal 
degradation. 
[15] 
Gelatine-fibrin Matrix 
hMSCs + 
hUVECs) + 
Human Neonatal 
Dermal Fibroblasts 
 Aerotech AGB 
10000 pneumatic 
syringe dispenser 
Bone 
Hydrogel in a 3D perfusion 
chip (725×650×125 mm). 
Viscosity: ≤1000 Pa. s 
 
Shear elastic modulus: 1-
10000 Pa 
 
Plateau modulus: 300-5000 
Pa 
 
A: Proliferation and differentiation into osteogenic lineage around vessels 
perfused with osteogenic medium. Cells survive for more than 6 weeks. Thick 
(>1 cm) vascularised construct.                                                                               
D: Weak mechanical properties of the construct due to gelatine and fibrin 
properties (not assessed). 
[12]
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Yield stress: 700-9000 Pa 
Alginate + PCL 
Porcine 
MSCs 
3D 
Discovery multi-
head pneumatic 
bioprinting system 
Bone 
Human vertebrae-like 
structures with orthogonal, 1 
mm PCL fibres in cell-laden 
alginate hydrogel. 
 
 
Compressive 
modulus: 1600 ± 100 Pa 
 
 
A: PCL reinforced mechanical properties of alginate. Construct 
promoted endochondral ossification and vascularisation post implantation. 
D: Co-printing of MSC-laden alginate with PCL not possible in 
smaller diameter constructs (<6 mm). Alginate and PCL not crosslinked, 
which could be a problem under high mechanical loads. Transition of the 
cartilage matrix into bone conducted in vitro and not in vivo. 
[13] 
Hydroxyapatite + 
Alginate + PVA 
Mouse calvaria 
3T3-E1 cells 
HyRel System 
30M with modified 
EMO-25 extruder 
Bone 
7-layer porous cylinders with 
1.5 cm diameter and 0.2 cm 
height.  
 
Storage Modulus: 275-
3572 Pa 
 
A: PVA-HA improve printability and viability. Good mechanical properties 
and scaffold integrity after 14 days. 
D: Simple structures printed and did not test cell differentiation. Invasive cell 
viability testing (rupture of the scaffold and incubation with sodium citrate), 
which may have effected remaining cells within scaffold. 
[39] 
Alginate + Collagen 
Pre-osteoblasts 
(MC3T3-E1) 
DTR2–2210T, 
Dongbu Robot, 
Bucheon, South 
Korea with a 
dispenser and an 
aerosol humidifier 
(Tess-7400; Paju, 
South Korea) 
Bone 
Porous structures 15 x 15 x 3.6 
mm  
Storage modulus: 5-500 Pa 
Loss modulus: 1-200 Pa 
Viscosity: 5-200 Pa. s 
A: Presence of ECM components gives suitable microenvironment. Good cell 
viability and proliferation. 
D: Poor mechanical properties and not all the tested gels permit cell 
proliferation and maturation to osteoblasts. 
[40] 
Nano-fibrillated cellulose/ 
Alginate 
Human nasal 
chondrocytes and 
human hBMSCs 
INKREDIBLE 
printer 
(CELLINK) 
Cartilage 15 x 15 x 3 mm 
Compressive stress: 14.9 
kPa at day 0 and up to 88.2 
kPa after 2 months post-
implantation 
A: In vivo implantation in nude mice for 60 days. 
D: Size of samples for compressive tests too small. 
[41] 
Nano-fibrillated cellulose 
+ Alginate + Hyaluronic 
acid 
Induced 
Pluripotent Stem 
Cells (IPSCs) + 
chondrocytes 
3D Discovery 
(RegenHu) 
Cartilage 7 x 7 x 1.2 mm N/A 
A: Co-culture permitted iPSCs differentiation into chondrocytes. Obtained 
hyaline cartilage-like tissue. 
D: Absence of mechanical testing. 
[19] 
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Gelatine/ Hyaluronic 
acid/ Fibrinogen + PCL 
Mouse C2C12 
myoblasts 
3T3 Fibroblasts 
Scaffolds 
implanted into 
nude rats 
Integrated Tissue-
Organ Printer 
(ITOP) 
Skeletal muscle 
type II 
15 x 5 x 1 mm 
Compound muscle action 
potential: 3.6 mV 
A: Good cell viability and induced nerve integration. 
D: Muscle function lower than positive control and did not investigate the 
therapeutic efficacy. 
[20] 
Porcine tibialis anterior 
muscle decellularised 
ECM + PCL 
Mouse C2C12 
myoblasts 
Integrated 
composite 
tissue/organ 
building system 
(ICBS) 
Skeletal muscle 
Parallel, diamond and chain 
architectures 
Viscosity: shear thinning 
from 50 to 0.1 Pa.s 
Ultimate tensile stress: 2-
3.5 KPa 
Elastic modulus: 9-12 KPa 
A: Good mechanical properties, structure and architecture compared to 
collagen hydrogels widely used for tissue regeneration. The bioink provided a 
suitable microenvironment for the cells.  
D: No in vivo assessment. 
[42] 
Hyaluronic acid/ 
Fibrinogen/ Gelatine + 
Polyurethane (PU) or 
PCL 
C2C12 myoblasts 
(with PU) and 3T3 
fibroblasts (with 
PCL) 
Integrated Organ 
Printer 
Muscle-tendon 
unit 
Cross sections 20 x 5 x 1 mm 
10% overlap region 
Young’s modulus: 45 MPa 
for PCL part 
Ultimate stress strain: 4.5-
5.5 MPa for 3 PCL, 
interface and PU part 
A: The scaffold was elastic in the muscle half and stiff on the tendon side. 
D: Mechanical testing of the whole scaffold is missing. 
[43] 
 
Table 2. Cell-laden approach for bioprinting of musculoskeletal tissues. 
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3. Musculoskeletal bioinks and their characteristics  
Bioinks are an integral part of the bioprinting process. Most frequently, they are defined as 
hydrogel materials used for the encapsulation of cells in 3D bioprinting [44]. However, this 
definition is very limited and there are a number of examples where biological materials 
without cells are also termed as bioinks [45]. Opinion on the exact definition of bioink remains 
divided. From the literature it is clear that cell-only [46] , cells with supporting materials (both 
synthetic and natural hydrogels) [13] and biomolecules without cells (BMP2) [47] are also 
referred to as bioinks. 
In the musculoskeletal context, the scenario is even more complex. As seen from the literature 
review in the previous section, musculoskeletal tissues have been bioprinted using three 
approaches: cell-free, cell-laden and combination of both approaches (i.e. multimode printing 
of synthetic polymers, along with encapsulated cells). The definition of bioinks becomes even 
hazier as the commonly used definition of encapsulated cells within material becomes very 
limited in its scope and application. We anticipate that as bioprinting research advances through 
the development of both hardware (3D printers) and novel materials which support this process, 
the need for an accurate and more inclusive definition will become apparent. Here we will 
focus on the various bioink used for musculoskeletal applications as reported in literature and 
define the requirements for the fabrication of functional MSK tissues.  Figure 8 shows physical-
chemical, biological and fabrication requirements for musculoskeletal bioinks. Most of these 
requirements are similar to soft tissue bioprinting, however they become specific for 
musculoskeletal applications when additional mechanical stiffness and rigidity is required to 
fabricate structurally competent tissues. 
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Figure 8. Characteristic requirements for bioinks in musculoskeletal tissue fabrication. 
 
In the body, cells are found in highly organised environments, which are rich in water, nutrients 
and growth factors [48]**. Due to their significant water content, hydrogels have been 
identified as a primary material for bioprinting. Additionally, their hydrophilic nature allows 
hydrogels to retain large volumes of water without preventing a variety of crosslinking methods 
to be applied during fabrication of 3D networks [49]. In addition to this, hydrogels can be 
formulated to respond to various external stimuli such as temperature, electric or magnetic 
fields, light, pressure and sound vibrations before, during or after printing process [50].  
Chemical factors including pH, solvent composition, ionic strength and molecular species also 
affect hydrogel properties. Therefore a good understanding of these parameters on printability, 
stability in both in vitro and in vivo environments become essential.  
Materials for bioprinting must be biocompatible and mimic natural cellular or tissue 
environment [51,52]. Specifically, materials used for cell encapsulation must mimic the natural 
environment of cells and it has been demonstrated that hydrogels based on extracellular matrix 
components permit this [53,54].   
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In terms of fabrication, printing materials should exhibit good printability and sufficient 
mechanical properties for cellular support and maintenance of the 3D structures [51]. For 
example, since highly viscous hydrogels are prone to clogging phenomena in the nozzles of 
extrusion-based printers, shear-thinning of some hydrogels, such as hyaluronic acid and 
peptide gels, can be advantageous [55,56]. However, it is important to adapt these hydrogels 
so they are able to ‘self-heal’ and maintain their printed structure once deposited [57]. Gelation 
time, along with the capacity to respond to physiological shear, tensile and compressive 
stresses, are other key parameters in bioprinting, which determine whether a printed construct 
can maintain its structure in a physiological environment  [58,59].  
Hydrogels for bioprinting of musculoskeletal tissues can be classified as natural or synthetic 
depending on their origin [60], [61] and the most common ones used in the literature are 
summarised in Table 3. 
Most natural hydrogels are based on components of the mammalian ECM, even though 
polymers from alternative sources such as algae are gaining interest [62]. Natural hydrogels 
show significant bioactivity compared to synthetic materials due to the intrinsic presence of 
biomolecules used for signalling, adhesion, biocompatibility and self-remodelling [2]. While 
bioactive components are important for cell growth and differentiation, the application of 
natural materials can lead to batch-to-batch variability, immunogenic reactions and disease 
transmission [63]**. Interestingly, it has been observed that natural polymers such as hyaluronic 
acid, laminin, fibronectin and collagen are more susceptible to cell-driven biodegradation [64].  
It is important to note that as well as individual components of the ECM, decellularised ECM 
has similarly been successfully utilised as bioinks in the printing of tissues analogues [65,66]. 
Tissue decellularised ECM can be obtained using chemical, physical, and biological treatments 
and provides an excellent representation of the natural ECM environment [67]. At the same 
time, decellularised ECM can lead to non-homogeneous cell seeding and immune reactions, if 
cellular components are not fully removed [67]. Furthermore, decellularisation treatments can 
damage the natural ECM and show poor mechanical properties in the material. 
Synthetic materials are advantageous in terms of reproducibility and ease of processing 
compared to natural polymers. These polymers can sometimes lead to immunogenic reactions 
after partial degradation but this can be controlled and accelerated with the addition of matrix 
metalloproteinases, which show excellent biocompatibility [68,69]. Furthermore, synthetic 
materials can be tailored to form complexes with ECM proteins by covalent crosslinking.  
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These covalently-bound molecules can be adhesion proteins or growth factors that enhance cell 
response within the hydrogels [58]. 
 
 Material Description Tissue Reference 
 Natural hydrogels 
 Alginate Polysaccharide derived from seaweed, which can be ionically crosslinked 
with CaCl2. A: Fast gelation, general ease of use and low cost. D: Low 
swelling properties can limit cell survival and growth in the long term, and 
weak mechanical properties (Compressive modulus ~10 KPa). CaCl2 
crosslinker can be cytotoxic at high concentrations. 
Bone [13,70] 
 Chitosan Polysaccharide derived from chitin and most commonly obtained from the 
exoskeletons of crustaceans. Commonly crosslinked using genipin or 
glutaraldehyde. A: Good biocompatibility, biodegradability, anti-
inflammatory/ antibacterial properties, and good printability.  Structure 
similar to GAGs in cartilage. D: Slow gelation and weak mechanical 
properties (Young’s modulus in compressive mode for non-crosslinked 
and genipin crosslinked films is 38.7 KPa and 87.3 KPa). Glutaraldehyde 
crosslinking is cytotoxic. 
Bone and 
Cartilage 
[71] 
 Collagen Protein composed of glycine, praline and arginine to form tropocollagen 
fibres of diameters ranging from 50 to 200 nm. A: Good swelling 
properties and biocompatibility. D: Weak mechanical strength (mean peak 
stress: 0.76 MPa), poor printability and expensive. 
Bone and 
Cartilage 
[72] 
 Fibrin Fibrin is a non-globular protein present in the blood produced during blood 
clotting. Can be enzymatically crosslinked. A: Good biocompatibility, 
swelling and gelation properties. Good printability. D: Weak mechanical 
properties and expensive. 
Bone [73] 
 Gelatine Protein obtained from hydrolysed collagen, which can be crosslinked 
using temperature and enzymes. A: Low cost, biocompatible, 
biodegradable with high-cell adhesion. D: Poor printability. Often found 
coupled to methyl acrylate (MA) to form GelMA (crosslinked with UV 
light and harmful to cells), which has significantly increased mechanical 
properties and improved printability compared to gelatine. 
Bone and 
Cartilage 
[74,75] 
 Hyaluronic 
acid (HA) 
Polysaccharide and major component of ECM.  (Photo) chemical 
crosslinking. A: Good biocompatibility, good swelling ratio (0-45) fast 
degradation rates (100 to 0% residual mass in 8 days). D: weak mechanical 
properties (storage modulus 400-1000 Pa, loss modulus 3-30 Pa) and 
limited printability due to shear-thinning. 
Bone [76] 
 dECM Tissue decellularized ECM can be obtained using chemical, physical, and 
biological treatments. A: Representative of natural ECM environment, 
tissue-specific, guides for stem cell differentiation and good 
biocompatibility. D: Non-homogeneous cell seeding and immune 
reactions if cellular components remain. Decellularization treatments can 
damage natural ECM. Poor mechanical properties: max storage modulus 
of 300 Pa and 0-20 Pa loss modulus. 
Bone 
 
 
 
Skeletal 
muscle 
[77] 
 
 
 
[42] 
 Synthetic hydrogels 
 Poly 
ethylene 
glycol (PEG) 
Synthetic polymer. Commonly crosslinked via chain-growth and step-
growth polymerisation, but can also be crosslinked using radiation and 
other chemical/ physical methods. A: FDA approved and does not trigger 
immunological responses. The material is soluble in water and organic 
solvents, and has low protein adhesion properties. Good diffusion of 
Bone [17] 
 20 
nutrients and oxygen, and cell migration. When coupled to methyl 
acrylate, it shows high swelling properties (swelling ratio from 37.88-
100.93%) and good biocompatibility. Compressive modulus of 30-65 KPa 
and 1.63-6.99 cP viscosity. Good printability. D: Often lack bioactive 
molecules.  
 Self-
assembling 
peptides 
Self-assembling peptide-based gels. A: Versatile properties that can be 
easily tailored by adjusting chemicals and physical parameters. Good 
extracellular matrix mimicry, while biocompatible and biodegradable.  
Bioactive molecules can be incorporated. D: Peptide gels are degraded by 
cellular proteolytic enzymes to cause shrinkage (20% of hydrogel volume 
in 12 days). Consequently, the mechanical properties become weaker 
(decrease from 50 to 10 Pa in 12 days). 
Bone [78] 
 
Table 3. Summary of the most popular hydrogels used for musculoskeletal bioprinting. Materials 
are categorised as natural or synthetic hydrogels, and the advantages (A) and disadvantages (D) of each 
material are described. 
 
4. Challenges in bioprinting of musculoskeletal tissues  
In addition to the hardware used for bioprinting, material availability and their selection are 
significant challenges and limitations for the success of bioprinting in musculoskeletal tissue 
fabrication. Materials/ bioinks composed of naturally derived materials are limited in their 
application due to batch to batch variability and often lack the mechanical strength required to 
mimic the in vivo environment of native musculoskeletal tissues [59]. In the literature, this 
issue is often resolved by combining the natural inks with stronger biocompatible materials, 
such as PCL, PLA and PLGA [28,33] as described previously.  
Furthermore, bioinks are presently limited by their printability and resolution. Materials are 
often required to be viscous in order to maintain the morphology of printed structures and 
improve mechanical strength, but this can lead to blockages and unreliable material deposition. 
Importantly, this has adverse effects on the print quality and resolution, which can be 
detrimental to achieving the highly hierarchical structures in the tissues of the musculoskeletal 
system.  
Tuneable, synthetic bioinks can provide a wide range of desirable properties, including 
controlled mechanics, degradation and printability. However, the techniques required to 
synthesise and crosslink these materials can cause cytotoxicity and prevent the ability to 
incorporate cells during the print process. For example, the monomers and photo initiators in 
some printable materials are toxic, but following UV crosslinking, the polymers formed are 
biocompatible and can support cell survival [79,80].  
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Further, printing of mechanically stable gelatine in the form of GelMA traditionally requires 
UV light during the print process and can damage cells. Recently, this challenge has been 
overcome by developing GelMA that can be crosslinked using visible light [81]. Crosslinking 
of natural bioinks can similarly be associated with cytotoxicity but this can often be alleviated 
by using low crosslinker concentrations or replacing with non-toxic analogues. For example, 
calcium chloride is used for crosslinking alginate, whereas glutaraldehyde is used for 
crosslinking collagen, gelatine, or chitosan. Calcium chloride is not toxic at low concentrations, 
while glutaraldehyde can be replaced with alternatives like genipin, during the crosslinking of 
collagen, gelatine and chitosan [82-84].  
Hydrogels are the most utilised materials in bioprinting, due to their high-water content and 
parallels to native ECM. However, these biomaterials show poor mechanical properties so 
compromises must be made when considering characteristics such as composition, printability 
and mechanical strength. In the bioprinting of musculoskeletal tissues this has been overcome 
to an extent by incorporating multiple printing technologies at the same time. This approach 
permits deposition of materials with good mechanical properties and cell-laden bioinks, within 
a single engineered construct [13,36].     
Furthermore, the fundamental layer-by-layer nature of most printing techniques leads to 
difficulties in producing complex and hollow structures. This can be resolved by incorporating 
sacrificial materials for structural support during the fabrication process but this also increases 
the technological complexity, cost and time of the printing. Once the resolution, 
reproducibility, speed and customisation of current printing technologies have been defined 
and optimised, bioprinting can provide cost-effective and high-throughput systems for drug 
screening and tissue replacement. Importantly, robust methods for construct maturation and 
long-term maintenance, as well as quality control measures for bioprinted tissues, need to be 
considered in parallel with the technological advances of printers. Regulatory concerns, such 
as the ethics of stem cells and the use of Class II medical devices are also key factors to 
contemplate, for the success of bioprinting approach. Furthermore, at present there are no 
specific 3D bioprinting regulations defined by the Medicines and Healthcare Products 
Regulatory Agency (MHRA) in the UK or Food and Drug Administration (FDA) in the USA.   
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5. Summary and future perspective 
Printing of natural ECM-based materials embedded with cells provides significant advantages 
for tissue engineering, including biocompatibility, robust control of cell distribution and 
density within the scaffold. Nevertheless, traditionally materials have been produced and 
seeded with cells afterwards, and this can also be applied to printed constructs. In fact, this 
approach permits scaffolds with enhanced mechanical properties and resolution that natural 
materials often lack for musculoskeletal applications. Furthermore, co-printing of cell-laden 
and cell-free materials has been revealed to be beneficial for musculoskeletal tissue engineering 
applications [13,31,36]. All these approaches (cell-laden, cell-free and a combination of both) 
aim to obtain a complex, living tissue able to develop and mature, using the same fundamental 
technology. 
The bioprinting literature suggests that the definition of bioinks remains unclear, considering 
various components such as cells, biomolecules, synthetic materials either alone or in 
combination, are defined as bioinks. Consensus in this matter is required. With the 
development of new bioinks in the future, nano-biofabrication of organs will become a reality 
and this will help to alleviate the increasing organ shortages worldwide. More specifically, 
technological advances in material science and engineering will permit versatility, nano-scale 
resolution and controllable distributing of cells and biomaterials, for a range of biomedical 
applications, including musculoskeletal repair.  
The literature shows that bioprinting of muscles, tendons and ligaments is still a challenge, 
however promising progress has been made in bioprinting of bone and cartilage. Stiff materials 
have been combined with natural cell-laden hydrogels to form composite constructs that are 
mechanically stable with the ability to mimic the native ECM environment of osteochondral 
tissues. Further, it has been demonstrated that these scaffolds can be combined with stem cells 
to permit osteochondral development in vivo [13]. Progress has even been made in the 
bioprinting of vascularised bone [14].  Bio-sensors for bone formation [85], and protein and 
DNA arrays of stem cells [86,87] have already been bioprinted, while next generation printable 
materials for controlling osteochondral cellular microenvironments are also in development. 
Nevertheless, these examples are all proof of concept studies and significant validation and 
development of next generation bioinks and their printing process is required in the future.  
Fundamentally, the success of bioprinting in tissue engineering is heavily reliant on 
improvements in bioink properties, printing technologies, vascularisation of tissues, and 
controlled scaffold and cell maturation. Crucially for bone and cartilage applications it is 
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important to improve the mechanical properties of bioinks and to maximise the resolution of 
the printed constructs. Innovative bioinks with benefits for musculoskeletal applications that 
are currently being developed include, dynamic switchable hydrogels with local variations in 
the density and size of collagen fibres throughout 3D tissues [88,89], and oxygen releasing 
biomaterials [90,91]. 
In conclusion, bioprinting promises to be an important tool to fabricate complex tissue and 
organs. However, there are significant challenges to be resolved in terms of technological 
advances. Research to date has laid strong foundations and promise for the feasibility in 
manufacturing artificial organs, including musculoskeletal tissues. Bioprinting and the use of 
bioinks remain developing and expanding multidisciplinary fields of research with substantial 
potential for the future successes of tissue engineering and regenerative medicine.  
 
 
 
Executive Summary 
Introduction 
 Successful translation of tissue engineering and regenerative medicine research relies on 
efficient, robust and cost-effective fabrication techniques.  
 Bioprinting is an automated additive manufacturing process that permits the fabrication of 
3D structures by selectively depositing biological materials layer-by-layer. 
Bioprinting and its role in musculoskeletal tissue fabrication  
 Bioprinting in the literature shows promise for musculoskeletal regeneration. 
 Greater understanding of the native environment in tissues and organs, is required to 
maintain cell viability. 
 Printer hardware needs to be developed to combine cell health with desired biomaterials 
characteristics. 
Musculoskeletal bioinks and their characteristics  
 Bioinks can be printable biological materials that must be compatible with the biological, 
chemical and physical requirements of native tissues. 
 To be suitable for musculoskeletal applications, a bioink must have suitable mechanical 
strength for cellular support and maintenance in 3D structures. 
 A range of natural and synthetic materials have been used for musculoskeletal applications. 
 Natural materials provide the biological properties for tissue development but lack the 
mechanical strength of bone and cartilage. Synthetic materials provide a solution to this 
challenge but are less bioactive.  
 The most promising examples in the literature, combine cell-free and cell-laden printing. 
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Challenges in bioprinting of musculoskeletal tissues  
 Bioinks cannot currently mimic the environments that cells experience in vivo. 
 Printing living cells is challenging because there are multiple variables that need to be 
controlled and optimised when cells are combined with biomaterials. 
 Hard tissues require mechanical strength that natural hydrogels often lack and synthetic 
materials can be detrimental to cell viability. 
Summary and future perspective 
 Bioinks must meet the following requirements: biocompatibility, biodegradability, good 
printability and sufficient mechanical strength for cellular support and maintenance of the 
3D structures.  
 The use of bioinks in bioprinting remains a developing and expanding multidisciplinary 
technology with substantial potential for the future successes of tissue engineering and 
regenerative medicine. 
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